The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis

Objective: to study the clinical efficacy, immunogenicity, and safety of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis (RA).Subjects and methods. The investigation enrolled 102 patients (78 women and 24 men, aged 23 – 70 years), including 72 patients with RA and 30 people wi...

Full description

Saved in:
Bibliographic Details
Main Authors: M. S. Naumtseva, B. S. Belov, G. M. Tarasova, D. E. Karateev, E. L. Luchikhina, Yu. V. Muravyev, E. N. Aleksandrova, A. A. Novikov
Format: Article
Language:Russian
Published: Numikom LLC 2015-08-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
rheumatoid arthritis
autoimmune diseases
comorbid infections
comorbidity
pneumonia
bronchitis
pneumococcal vaccine
vaccination
immunogenicity
efficacy
tolerability
Online Access:https://www.epidemvac.ru/jour/article/view/384
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.epidemvac.ru/jour/article/view/384

Similar Items